Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575939 · ClinicalTrials.gov registry record
Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 120
- Enrollment target
NCT00575939 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 120 participants.
The verdict
NCT00575939 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
It is well known that HIV-infected subjects frequently experience hyperlipidemias, insulin resistance, and visceral adiposity, which are known to increase the risk of atherosclerosis. Several cohorts have shown an increased risk of heart disease in people with HIV. The effect of HIV treatment versus HIV itself on the incidence of heart disease is unclear. In this study the investigators will assess the effect on carotid IMT of the initiation of antiretroviral combinations that are known to have a minimal effect on lipids and insulin resistance. We will also assess the changes in several inflammation and cardiovascular markers,as well as endothelial activation markers,and how these changes relate to therapy-induced changes in immunologic, virologic and metabolic markers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2007-11 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00575939
The ClinicalTrials.gov registry entry for NCT00575939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00575939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00575939 about?
NCT00575939 is a clinical study titled "Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV". It is well known that HIV-infected subjects frequently experience hyperlipidemias, insulin resistance, and visceral adiposity, which are known to increase the risk of atherosclerosis. Several cohorts have shown an increased risk of heart disease in people with HIV. The effect of HIV treatment versus...
What is the current status of trial NCT00575939?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2007-11. Estimated completion is 2014-11.
Who is sponsoring clinical trial NCT00575939?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.